Endothelial cell therapy may play role in cornea donation
Click Here to Manage Email Alerts
The IOTA study and a phase 2 risuteganib trial led recent cornea/external disease coverage on Healio/OSN.
Check out some of the top-performing items below.
IOTA study: One donor cornea may help treat ‘hundreds of patients’
Instead of using one donor cornea for one patient, endothelial cell therapy may allow tissue from one donor to be used by as many as 100 patients. Read more.
VIDEO: Donnenfeld discusses risuteganib for dry eye disease
Eric D. Donnenfeld, MD, discusses the FDA phase 2 trial of risuteganib in patients with dry eye disease. Watch here.
Diagnosis key for proper treatment of infectious keratitis
Many cases of Acanthamoeba keratitis are misdiagnosed. Read more.
Compounded cyclosporine may be option for dry eye treatment
Klarity-C was a suitable alternative treatment for patients with dry eye disease, according to a study published in Clinical Ophthalmology. Read more.
Artificial endothelial layer reduces corneal edema, pain
A polymer film implant attached to the posterior corneal surface can treat corneal edema secondary to endothelial dysfunction and may be an alternative to endothelial keratoplasty. Read more.
Collapse
Healio Coverage
Read more about
Click Here to Manage Email Alerts